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Differential temporal control of Foxa.a and Zic-r.b specifies brain
versus notochord fate in the ascidian embryo
Tatsuro Ikeda* and Yutaka Satou
ABSTRACT
In embryos of an invertebrate chordate, Ciona intestinalis, two
transcription factors, Foxa.a and Zic-r.b, are required for
specification of the brain and the notochord, which are derived
from distinct cell lineages. In the brain lineage, Foxa.a and Zic-r.b
are expressed with no temporal overlap. In the notochord lineage,
Foxa.a and Zic-r.b are expressed simultaneously. In the present
study, we found that the temporally non-overlapping expression of
Foxa.a and Zic-r.b in the brain lineage was regulated by three
repressors: Prdm1-r.a (formerly called BZ1), Prdm1-r.b (BZ2)
and Hes.a. In morphant embryos of these three repressor genes,
Foxa.a expression was not terminated at the normal time, and
Zic-r.b was precociously expressed. Consequently, Foxa.a and
Zic-r.b were expressed simultaneously, which led to ectopic
activation of Brachyury and its downstream pathways for
notochord differentiation. Thus, temporal controls by transcriptional
repressors are essential for specification of the two distinct fates of
brain and notochord by Foxa.a and Zic-r.b. Such a mechanism
might enable the repeated use of a limited repertoire of transcription
factors in developmental gene regulatory networks.
KEY WORDS: Ciona intestinalis, Transcriptional repressor,
Temporal regulation
INTRODUCTION
In animal development, many transcription factors are used
reiteratively in different combinations at different places and
times. In embryos of the invertebrate chordate Ciona intestinalis,
Foxa.a, Zic-r.b (formerly ZicL, renamed according to a recently
published nomenclature rule; Stolfi et al., 2015) and Fgf signaling
are used for specifying the developmental fates of the notochord and
the brain. In the anterior (A-line) notochord lineage, Foxa.a and Zic-
r.b are expressed simultaneously in the same cells from the 32-cell
to the gastrula stage (Imai et al., 2002a, 2004). Fgf9/16/20 is
expressed in the vegetal hemisphere from the 16-cell to the early
gastrula stage (Imai et al., 2002b). Foxa.a, Zic-r.b and Fgf signaling
combinatorially activate Brachyury at the 44-cell stage (Imai et al.,
2002a, 2006; Yagi et al., 2004; Yasuo and Hudson, 2007).
Brachyury encodes a key transcription factor for specifying the
notochord, and activates notochord-specific genes directly and
indirectly (Chiba et al., 2009; Hotta et al., 2000; Katikala et al.,
2013; Kubo et al., 2010; Takahashi et al., 1999). Indeed, in another
ascidian species, Halocynthia roretzi, overlapping expression of
Foxa and ZicN (an ortholog of Zic-r.b) and activation of Ets by Fgf
signaling have been reported to be required for Brachyury
expression (Kumano et al., 2006; Matsumoto et al., 2007; Miya
and Nishida, 2003).
Similarly, Foxa.a, Zic-r.b and Fgf signaling are all required for
specifying the brain fate in Ciona (Bertrand et al., 2003; Hudson
et al., 2003; Imai et al., 2002a, 2006; Lamy et al., 2006; Wagner
and Levine, 2012). However, in the brain lineage, Foxa.a is
expressed from the 8- to the 32-cell stage, whereas Zic-r.b is
expressed from the early gastrula to the neurula stage (Imai et al.,
2002a, 2004; Shimauchi et al., 2001). Thus, Foxa.a and Zic-r.b
are expressed sequentially, not simultaneously, in the brain
lineage. In addition, the brain-lineage cells continuously receive
the Fgf signal from the vegetal hemisphere from the 32-cell to the
early gastrula stage (Hudson et al., 2003; Wagner and Levine,
2012).
Three transcriptional repressors, Prdm1-r.a (formerly BZ1),
Prdm1-r.b (formerly BZ2) and Hes.a are important for ensuring
that Foxa.a and Zic-r.b are expressed sequentially in the
presumptive brain cells, as indicated by the fact that Zic-r.b is
precociously expressed at the 32-cell stage in triple morphants of
Prdm1-r.a, Prdm1-r.b and Hes.a (Prdm1-r.a/b/Hes.a morphants)
(Ikeda et al., 2013). In the present study, we show that Prdm1-r.a
also promotes termination of Foxa.a expression, and we propose a
robust mechanism for temporally distinct expression of Foxa.a and
Zic-r.b to ensure the brain lineage specification.
RESULTS AND DISCUSSION
The notochord developmental program was ectopically
activated in Prdm1-r.a/b/Hes.amorphants
We previously showed that Zic-r.b is precociously expressed in bi-
potential brain/palp progenitors at the 64-cell stage in double-
morphant embryos of Prdm1-r.a and Prdm1-r.b (Prdm1-r.a/b
morphants), and this ectopic activation of Zic-r.b converts palp fate
into brain fate (Ikeda et al., 2013). We also showed that Zic-r.b
expression begins earlier (at the 32-cell stage) in Prdm1-r.a/b/Hes.a
triple morphants. However, Prdm1-r.a/b/Hes.amorphant larvae are
severely disorganized (probably because Hes.a is expressed in the
endomesodermal lineages in addition to the ectodermal lineages),
and therefore we cannot analyze their morphology. To overcome
this problem, in the present study, we injected morpholino
oligonucleotides (MOs) into the pair of anterior animal (a-line)
blastomeres of 8-cell embryos, from which ectodermal tissues,
including the brain and the palps, are derived.
Prdm1-r.a/b/Hes.a morphant larvae lost not only palps but also
the otolith and ocellus in the brain (Fig. 1A,B), whereasPrdm1-r.a/b
morphant larvae lost only palps (Ikeda et al., 2013). In addition,Hes.
a single-morphant larvae did not lose palps, otolith or ocellus
(Fig. 1C). Thus, Prdm1-r.a/b/Hes.amorphant larvae showed amore
severe phenotype than Prdm1-r.a/b morphant larvae and Hes.a
morphant larvae.Received 12 July 2016; Accepted 14 November 2016
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In some Prdm1-r.a/b/Hes.a morphants, the notochord appeared
to be longer than that in normal embryos. Indeed, Noto1 and Fgl
(formerly Fibrinogen-like), which are markers for notochord (Hotta
et al., 2000), were expressed ectopically in the trunk region of
Prdm1-r.a/b/Hes.a morphant tailbud embryos (Fig. 1D-G). Cells
that ectopically expressed Noto1 and Fgl were derived from the
anterior animal blastomeres of 8-cell embryos, as indicated by
our finding that lacZ mRNA, injected as a tracer together with
Noto1
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Fig. 1. Prdm1-r.a/b/Hes.a morphants show ectopic
activation of the notochord developmental program.
(A-C) Tadpole larvae developed from embryos injected with a
control MO (A), Prdm1-r.a/Prdm1-r.b/Hes.a MOs (B) or
Hes.a MO (C). Magenta, yellow and cyan arrowheads
indicate palps, otolith and ocellus, respectively. (D-G) The
expression ofNoto1 (D,E) and Fgl (F,G) at the tailbud stage in
embryos injected with a control MO (D,F) or Prdm1-r.a/
Prdm1-r.b/Hes.a MOs (E,G). Cyan arrowheads indicate
ectopic expression. Percentages of embryos with ectopic
expression are shown. (H-J) Double fluorescence in situ
hybridization of tailbud embryos injected with Prdm1-r.a/
Prdm1-r.b/Hes.aMOs concomitantly with lacZmRNA. Green
and magenta indicate expression of Noto1 and lacZ,
respectively. Percentage of embryos with simultaneous
expression of Noto1 and lacZ is shown. All MOs were
injected into the pair of anterior animal cells at the 8-cell







































































































Fig. 2. Brachyury was ectopically expressed in
Prdm1-r.a/b/Hes.a morphants. (A-I) Brachyury
expression at the 64-cell (A,D,G), early gastrula (B,B′,E,
E′,H,H′) and late gastrula (C,F,I) stages in embryos
injected with a control MO (A-C), Prdm1-r.a/Prdm1-r.b/
Hes.a MOs (D-F) or Prdm1-r.a/Prdm1-r.b MOs (G-I).
Cyan arrowheads indicate ectopic expression in the a-
line. Black arrowheads indicate expression in the
notochord progenitors. Percentages of embryos with
ectopic expression are shown. n, number of embryos
examined.
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Prdm1-r.a, Prdm1-r.b and Hes.a MOs, was detected in the same
cells that expressed Noto1 (Fig. 1H-J). Thus, Prdm1-r.a, Prdm1-r.b
and Hes.a suppress the developmental program of the notochord in
the anterior animal cells.
Brachyurywas ectopically activated in the brain progenitors
of Prdm1-r.a/b/Hes.amorphants
Brachyury is a key gene for notochord differentiation (Chiba et al.,
2009; Yasuo and Satoh, 1993, 1998). We found that Brachyurywas
expressed ectopically in the presumptive brain/palp cells of Prdm1-
r.a/b/Hes.a morphants from the 64-cell to the gastrula stage
(Fig. 2A-F).
Although a small fraction of Prdm1-r.a/b double morphants also
expressed Brachyury weakly in the presumptive brain/palp cells
(Fig. 2G-I), they rarely expressed Noto1 or Fgl ectopically
(Fig. S1A,B). Single morphants of either Prdm1-r.a, Prdm1-r.b
or Hes.a did not express Brachyury ectopically (Fig. S1C-E). These
data suggest that strong ectopic activation of Brachyury led to
ectopic expression of Noto1 and Fgl in the brain progenitors of
Prdm1-r.a/b/Hes.a morphants.
Prdm1-r.a causes Fox a.a expression to be transient
Previous studies showed that Foxa.a, Zic-r.b and Fgf signaling are
required for activating Brachyury expression (Imai et al., 2002a,
2006; Yagi et al., 2004; Yasuo and Hudson, 2007). The cells with
the brain/palp fates receive Fgf signaling continuously from the 32-
cell to the early gastrula stage, and Zic-r.b begins to be expressed at
the 32-cell stage in Prdm1-r.a/b/Hes.a morphants (Hudson et al.,
2003; Ikeda et al., 2013; Wagner and Levine, 2012). Based on these
observations, we examined whether Foxa.a expression was also
changed in Prdm1-r.a/b/Hes.amorphants. In the brain/palp lineage,
Foxa.a is expressed between the 8- and the 32-cell stages in normal
embryos. At the 32-cell stage, Foxa.a was expressed normally in
embryos injected with either control, Prdm1-r.a, Prdm1-r.b or
Hes.a MO (Fig. 3A-E). At the 64-cell stage, Foxa.a expression
































































































Fig. 3. Prdm1-r.a causes termination of Foxa.a expression.
(A) Schematics of embryos at the 32-cell, 64-cell and early
gastrula stages in lateral views. The a-line cells are colored in
magenta. (B-E) Foxa.a expression at the 32-cell, 64-cell and
early gastrula stages in embryos injected with control (B),
Prdm1-r.a (C), Prdm1-r.b (D) or Hes.a (E) MO (shown in lateral
views; animal pole right). Cyan arrowheads indicate expression in
the a-line. Percentages of embryos with Foxa.a expression in the
a-line cells are shown. (F-I) Foxa.a expression in 16-cell embryos
injected with control Gfp (F), Prdm1-r.a (G), Prdm1-r.b (H) or
Hes.a (I) mRNA (shown in lateral views; animal pole right).
Magenta arrowheads indicate loss of expression. Percentages of
embryos that showed thewild-type expression pattern are shown.
n, number of embryos examined.
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either control, Prdm1-r.b or Hes.a MO (Fig. 3B,D,E). However, in
Prdm1-r.amorphants, Foxa.a continued to be expressed even at the
early gastrula stage (Fig. 3C). Consistent with this, Foxa.a
expression was drastically decreased in 16-cell embryos injected
with Prdm1-r.a mRNA (Fig. 3G), but not in embryos injected with
mRNA of Gfp (control) or Hes.a (Fig. 3F,I). Because 59% of
embryos injected with Prdm1-r.b mRNA lost Foxa.a expression in
one or more cells, Prdm1-r.b could repress Foxa.a expression
(Fig. 3H). Thus, Prdm1-r.a negatively regulates Foxa.a expression,
and therefore Foxa.a expression ceases at the 64-cell stage. Prdm1-
r.b might also contribute to this repression.
Simultaneous expression of Foxa.a and Zic-r.b leads to
ectopic Brachyury expression
The preceding results indicated that simultaneous expression of
Foxa.a and Zic-r.b activated Brachyury in the brain/palp lineage, in
which cells continuously receive Fgf signaling. The ectopic
expression of Brachyury in Prdm1-r.a/b/Hes.a morphants did
indeed depend on Foxa.a, Zic-r.b and Fgf signaling, as indicated by
the following two findings. First, Prdm1-r.a/b/Hes.a morphants
treated with U0126 (which inhibits the Fgf signaling pathway) from
the 44-cell stage did not express Brachyury (Fig. 4A,B). Second,
ectopic Brachyury expression was lost when we injected either
Foxa.a or Zic-r.b MO concomitantly with Prdm1-r.a, Prdm1-r.b
andHes.aMOs (Fig. 4C-E). Because Foxa.a begins to be expressed
earlier than Zic-r.b in the brain lineage of normal embryos, there is a
possibility that Foxa.a activates Zic-r.b expression. However, when
we injected Foxa.aMO into the pair of anterior animal cells of 8-cell
embryos, Zic-r.b expression was not lost (Fig. S2). Thus, Foxa.a
does not activate Zic-r.b expression in the brain lineage, and Foxa.a
and Zic-r.b are required for the ectopic Brachyury expression.
Our results clearly show that the combination of Foxa.a, Zic-r.b
and Fgf signaling can activate Brachyury even in the brain/palp
lineage. Thus, the temporal control of expression of Foxa.a and Zic-
































































































































Fig. 4. Temporal misregulation leads to
ectopic Brachyury expression.
(A-E) Brachyury expression at the 64-cell
stage in Prdm1-r.a/b/Hes.a morphant
embryos treated with DMSO (A) or U0126
(B), and in embryos injected with
Prdm1-r.a/Prdm1-r.b/Hes.a MOs (C-E)
concomitantly with control (C), Foxa.a (D)
or Zic-r.b (E) MO. In C-E, all MOs were
injected into the pair of anterior animal
cells at the 8-cell stage. Percentages of
embryos with ectopic expression are
shown. All embryos are shown in anterior
views. n, number of embryos examined.
(F) The amount of Prdm1-r.a mRNA was
measured by RT-qPCR in wild-type
embryos at the 16- and 32-cell stages. The
level of a maternal mRNA, Zic-r.a (Macho-
1), was used as an endogenous control.
The y-axis shows relative expression
compared with expression at the 16-cell
stage. ***P<0.001; two-tailed paired t-test.
Data are mean±s.d. (G) The amount of
Prdm1-r.a mRNA at the 32-cell stage was
measured by RT-qPCR in controls or
Foxa.a morphants treated with DMSO or
U0126 from the 16-cell stage. The level of
Zic-r.a was used as an endogenous
control. The y-axis shows relative
expression compared with expression in
embryos injected with control MO and
treated with DMSO. Error bars indicate
mean±s.d. between two technical
duplicates. *P<0.05, **P<0.01; two-tailed
paired t-test. In F andG, the results of three
and four independent experiments are
shown in different colors. (H) Summary of
temporal regulation of Foxa.a, Zic-r.b and
Fgf signaling. This regulation enables
these three factors to be used repeatedly
for specification of the brain and the
notochord fates.
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r.b is essential for preventing Brachyury from being expressed in the
brain/palp lineage. Interestingly, expression of early neural marker
genes, Otx, Dmrt1 and Celf3 (formerly Etr) (Hudson and Lemaire,
2001; Hudson et al., 2003; Imai et al., 2004), was not lost in the
brain/palp lineage of Prdm1-r.a/b/Hes.a morphants (Fig. S3). This
suggests that Prdm1-r.a, Prdm1-r.b and Hes.a are not required for
activating the early neural program.
Foxa.a and Fgf signaling enhance Prdm1-r.a expression at
the 32-cell stage
Prdm1-r.a begins to be expressed at the 16-cell stage (Ikeda et al.,
2013). Although it was therefore expected that Prdm1-r.a protein
would repress Foxa.a at the 32-cell stage, we found that Foxa.awas
not repressed before the 64-cell stage (Fig. 3B). To understand this
delay, we measured the amount of Prdm1-r.a mRNA at the 16- and
32-cell stages by reverse transcription followed by quantitative PCR
(RT-qPCR), and found that the amount of Prdm1-r.a mRNA was
19-fold greater at the 32-cell stage than at the 16-cell stage (Fig. 4F).
Foxa.a and Fgf signaling were necessary for this increase
between the 16- and 32-cell stages. RT-qPCR showed that
Prdm1-r.a expression was significantly reduced in embryos
treated with U0126, Foxa.a morphants, and Foxa.a morphants
treated with U0126 (Fig. 4G). We confirmed this result by in situ
hybridization (Fig. S4).
Conclusions
Knockdown of Prdm1-r.a and Prdm1-r.b resulted in precocious
expression of Zic-r.b at the 64-cell stage, and expansion of the brain
region at the expense of anterior placode-like cells (Ikeda et al.,
2013). Triple knockdown of Prdm1-r.a, Prdm1-r.b and Hes.a
evoked precocious Zic-r.b expression even at the 32-cell stage, and
subsequently evoked ectopic expression of notochord marker genes
in the brain/palp lineage. This difference in phenotypes between
Prdm1-r.a/b and Prdm1-r.a/b/Hes.a morphants was likely due to a
difference of the duration of overlap of expression of Foxa.a and
Zic-r.b.
Our results showed that temporal overlap of the expression of
Foxa.a and Zic-r.b activates Brachyury and its downstream
pathways for notochord differentiation under the control of Fgf
signaling even in the brain/palp lineage. Thus, temporal control of
gene expression by the transcriptional repressors Prdm1-r.a, Prdm1-
r.b and Hes.a is important for proper function of the gene regulatory
network. Prdm1-r.a, Prdm1-r.b and Hes.a enable the same
combination of Foxa.a, Zic-r.b and Fgf signaling to be used
repeatedly, but with different timings, for specification of the brain
versus the notochord (Fig.4H). Temporal control by transcriptional
repressors might have played an important role in the evolution of
gene regulatory networks, because animal embryos develop a
variety of cell types by reiteratively using a limited repertoire of
transcription factors.
The extended notochord in Prdm1-r.a/b/Hes.a morphants is
evocative of the notochord in cephalochordates, in which the
notochord extends into the head. Acquisition of the temporal control
by Prdm1-r.a, Prdm1-r.b andHes.amight represent a key event that
excluded the notochord program from the head region after the
divergence of ascidians and amphioxus.
MATERIALS AND METHODS
Animals, Fgf inhibition and gene identifiers
Ciona intestinalis adults (type A) were obtained from the National Bio-
Resource Project for this animal. U0126 (Sigma) was used at 10 μM as
described in a previous study (Hudson et al., 2003). Identifiers for genes
examined in the present study are as follows: CG.KH2012.C11.313 for
Foxa.a, CG.KH2012.C12.493 for Prdm1-r.a, CG.KH2012.C12.105 for
Prdm1-r.b, CG.KH2012.C1.159 for Hes.a, CG.KH2012.S1404.1 for
Brachyury, CG.KH2012.S816.1 for Zic-r.b, CG.KH2012.L20.18 for
Noto1, CG.KH2012.C1.832 for Fgl, CG.KH2012.C1.727 for Zic-r.a
(formerly Macho-1), CG.KH2012.C4.84 for Otx, CG.KH2012.S544.3 for
Dmrt1 and CG.KH2012.C6.128 for Celf3.
Gene knockdown and overexpression
For gene knockdown, we used the same MOs (Gene Tools) for Prdm1-r.a,
Prdm1-r.b, Foxa.a, Hes.a and Zic-r.b that we used in previous studies
(Ikeda et al., 2013; Imai et al., 2006). We also used a standard control MO
(5′-CCTCTTACCTCAGTTACAATTTATA-3′) purchased from Gene
Tools.
Synthetic transcripts of lacZ, Gfp, Prdm1-r.a, Prdm1-r.b and Hes.awere
prepared from cDNA cloned into the pBluescript RN3 vector (Lemaire
et al., 1995) using an mMESSAGE mMACHINE T3 Kit (Thermo Fisher
Scientific), and injected into fertilized eggs (1 mg/ml). All knockdown and
overexpression phenotypes were confirmed in at least two independent
injections.
RT-qPCR
For RT-qPCR, RNA extracted from 20-51 embryos was reverse-transcribed
with an oligo-dT primer. The cDNA samples thus obtained were then
analyzed by quantitative PCR with the SYBR-Green method. For each
qPCR, the amount of cDNA used was equivalent to that in one embryo. The
amount of maternal Zic-r.amRNAwas measured as an endogenous control.
We used the same primers that we used previously (Ikeda et al., 2013).
In situ hybridization
The detailed procedure for whole-mount in situ hybridization was described
previously (Ikuta and Saiga, 2007; Satou et al., 1995). We synthesized a
probe for Prdm1-r.a using the same cDNA that we used previously (Ikeda
et al., 2013).
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Kugler, J. E., Oda-Ishii, I., Imai, J. H., Nibu, Y. and Di Gregorio, A. (2013).
Functional Brachyury binding sites establish a temporal read-out of gene
expression in the Ciona notochord. PLoS Biol. 11, e1001697.
Kubo, A., Suzuki, N., Yuan, X., Nakai, K., Satoh, N., Imai, K. S. and Satou, Y.
(2010). Genomic cis-regulatory networks in the early Ciona intestinalis embryo.
Development 137, 1613-1623.
Kumano, G., Yamaguchi, S. and Nishida, H. (2006). Overlapping expression of
FoxA and Zic confers responsiveness to FGF signaling to specify notochord in
ascidian embryos. Dev. Biol. 300, 770-784.
Lamy, C., Rothbächer, U., Caillol, D. and Lemaire, P. (2006). Ci-FoxA-a is the
earliest zygotic determinant of the ascidian anterior ectoderm and directly
activates Ci-sFRP1/5. Development 133, 2835-2844.
Lemaire, P., Garrett, N. andGurdon, J. B. (1995). Expression cloning of Siamois, a
xenopus homeobox gene expressed in dorsal-vegetal cells of blastulae and able
to induce a complete secondary axis. Cell 81, 85-94.
Matsumoto, J., Kumano, G. and Nishida, H. (2007). Direct activation by Ets and
Zic is required for initial expression of the Brachyury gene in the ascidian
notochord. Dev. Biol. 306, 870-882.
Miya, T. and Nishida, H. (2003). An Ets transcription factor, HrEts, is target of FGF
signaling and involved in induction of notochord, mesenchyme, and brain in
ascidian embryos. Dev. Biol. 261, 25-38.
Satou, Y., Kusakabe, T., Araki, L. and Satoh, N. (1995). Timing of initiation of
muscle-specific gene expression in the ascidian embryo precedes that of
developmental fate restriction in lineage cells. Dev. Growth Differ. 37,
319-327.
Shimauchi, Y., Chiba, S. and Satoh, N. (2001). Synergistic action of HNF-3 and
Brachyury in the notochord differentiation of ascidian embryos. Int. J. Dev. Biol.
45, 643-652.
Stolfi, A., Sasakura, Y., Chalopin, D., Satou, Y., Christiaen, L., Dantec, C., Endo,
T., Naville, M., Nishida, H., Swalla, B. J. et al. (2015). Guidelines for the
nomenclature of genetic elements in tunicate genomes. Genesis 53, 1-14.
Takahashi, H., Hotta, K., Erives, A., Di Gregorio, A., Zeller, R. W., Levine, M. and
Satoh, N. (1999). Brachyury downstream notochord differentiation in the ascidian
embryo. Genes Dev. 13, 1519-1523.
Wagner, E. and Levine, M. (2012). FGF signaling establishes the anterior border of
the Ciona neural tube. Development 139, 2351-2359.
Yagi, K., Satou, Y. and Satoh, N. (2004). A zinc finger transcription factor, ZicL, is a
direct activator of Brachyury in the notochord specification of Ciona intestinalis.
Development 131, 1279-1288.
Yasuo, H. and Hudson, C. (2007). FGF8/17/18 functions together with FGF9/16/20
during formation of the notochord in Ciona embryos. Dev. Biol. 302, 92-103.
Yasuo, H. and Satoh, N. (1993). Function of vertebrate T gene. Nature 364,
582-583.
Yasuo, H. and Satoh, N. (1998). Conservation of the developmental role of
Brachyury in notochord formation in a urochordate, the ascidian Halocynthia
roretzi. Dev. Biol. 200, 158-170.
43
RESEARCH REPORT Development (2017) 144, 38-43 doi:10.1242/dev.142174
D
E
V
E
LO
P
M
E
N
T
